SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
JLL Income Property Trust's Board declared a monthly dividend of $0.0525 per share for July 2026, payable on or around July 24, 2026. The press release explicitly announces this distribution declaration and provides details on the annualized distribution rate (approximately 5.6% on NAV of $11.27). This is a routine but material dividend declaration typical of REIT disclosures, affecting investor returns and capital allocation decisions.
View raw filing on EDGAR →The filing discloses the issuance of consolidated obligation bonds by the Federal Home Loan Bank of San Francisco under Item 2.03. Schedule A reports a $15 million bond with a trade date of 7/07/2026, settlement date of 7/16/2026, and maturity date of 7/16/2029, with a 4.300% coupon. This represents the creation of a direct financial obligation through debt issuance, which is the core purpose of Item 2.03 disclosures.
View raw filing on EDGAR →The filing discloses the creation of multiple direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines. Schedule A lists specific debt securities issued on trade dates in July 2026, with principal amounts totaling approximately $4.6 billion across variable-rate floaters and fixed-rate callable bonds. This is a classic debt issuance disclosure under Item 2.03, material to investors assessing the Bank's capital structure and funding activities.
View raw filing on EDGAR →The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Topeka. Schedule A details eight separate debt issuances with trade dates of 07/06/2026 and 07/07/2026, totaling approximately $2.1 billion in principal across fixed-rate bonds and variable-rate floaters with maturities ranging from November 2026 to July 2046. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations of the registrant.
View raw filing on EDGAR →The filing discloses the issuance of a Consolidated Bond with a principal amount of $15,000,000, trade date 7/6/2026, maturing 10/9/2029, at a 4.400% coupon rate. This represents a direct financial obligation created by the FHLB through the sale of debt securities in the capital markets, which is the core purpose of Item 2.03 disclosures. The filing explicitly states that "Consolidated Obligations issuance is material to the FHLB," and debt issuance by a Federal Home Loan Bank is material to investors assessing the registrant's capital structure and funding activities.
View raw filing on EDGAR →The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A lists multiple debt securities issued on trade dates of 7/6/2026 and 7/7/2026, with principal amounts totaling approximately $3.63 billion across various maturities and rate structures. This is a classic debt issuance under Item 2.03, and the registrant explicitly notes that "consolidated obligations issuance is material to the FHLBank."
View raw filing on EDGAR →The filing discloses the issuance of consolidated obligation bonds totaling $165 million across three trade dates (7/6/2026 and 7/7/2026) with maturities ranging from 2030 to 2051. Schedule A explicitly lists the principal amounts, CUSIPs, settlement dates, coupon rates, and call provisions for these newly issued debt securities. The Bank notes that "consolidated obligations issuance is material to the Bank," and the Item 2.03 classification confirms this is a creation of direct financial obligations through debt issuance in the capital markets.
View raw filing on EDGAR →The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Boston. Schedule A details two specific debt issuances on trade date 7/7/2026: a $15 million bond maturing 7/20/2028 with a 4.350% coupon and a $50 million discount note maturing 2/5/2027 with a 3.920% coupon. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations of the registrant.
View raw filing on EDGAR →The filing discloses the creation of a direct financial obligation through the issuance of consolidated obligation bonds by the Federal Home Loan Bank of Atlanta. Schedule A reports a $10 million bond with a trade date of 7/7/2026, settlement date of 7/10/2026, and maturity date of 7/10/2031, with a 4.35% coupon. This is a classic debt issuance under Item 2.03, creating a new direct financial obligation for the Bank.
View raw filing on EDGAR →The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds with aggregate par value of $50 million across three tranches (maturing 2028, 2029, and 2031 with coupons ranging from 4.250% to 4.650%). This is a direct creation of financial obligations under Item 2.03, constituting a material debt issuance by the registrant.
View raw filing on EDGAR →The filing discloses the creation of a direct financial obligation through the issuance of a consolidated obligation bond by the Federal Home Loan Bank of Dallas. Schedule A reports a $20 million bond committed to be issued on 7/6/2026 with a 5.9% coupon and 25-year maturity (7/20/2051). This is a classic debt issuance under Item 2.03, creating a new direct financial obligation for the registrant.
View raw filing on EDGAR →Brookdale issued a press release on July 9, 2026 announcing occupancy metrics for June 2026 and quarterly results for the period ended June 30, 2026, including consolidated and same-community occupancy data with year-over-year and sequential comparisons.
View raw filing on EDGAR →This exhibit is a press release announcing Ryoncil® net revenue of US$36 million for Q4 FY2026 and US$115 million for the full fiscal year ended June 30, 2026. The disclosure presents quarterly and annual financial results for the company's lead commercial product, with management commentary on revenue growth exceeding initial projections and anticipated continued growth. This is a classic earnings release announcing periodic financial results.
View raw filing on EDGAR →Main Street Capital issued a press release on July 9, 2026 disclosing second quarter 2026 portfolio activity, including originations of $319.0 million in new or increased commitments and $238.9 million in funded investments across its private loan portfolio. This is a quarterly operational and financial results disclosure typical of earnings releases filed under Item 2.02, providing investors with material information about the company's investment activity and portfolio composition as of June 30, 2026.
View raw filing on EDGAR →Alterity announced receipt of an A$3.98 million R&D tax refund from the Australian Government for the 2025 financial year. This is a material cash inflow that affects the company's liquidity and funding position for its clinical programs, but does not fit neatly into standard event categories (not debt issuance, dividend, or capital raise). It is clearly a financial event—a government tax incentive payment—that would affect a reasonable investor's assessment of the company's cash position and runway.
View raw filing on EDGAR →The press release announces ConnectOne Bancorp's plan to release second quarter 2026 financial results on July 23, 2026, and to host a conference call with Chairman and CEO Frank Sorrentino III and CFO William S. Burns to review the Company's financial performance and operating results. This is a standard earnings release announcement disclosing quarterly financial results, which is material to investors assessing the registrant's financial condition and performance.
View raw filing on EDGAR →This is a clear earnings release disclosing Byrna Technologies' financial results for the fiscal second quarter ended May 31, 2026. The press release, attached as Exhibit 99.1, reports net revenue of $16.4 million (down 43% year-over-year), a net loss of $(10.1) million (versus net income of $2.4 million in Q2 2025), and includes material non-cash charges including a $5.9 million inventory write-down and $3.5 million equipment impairment. The disclosure is material as it reflects significant operational challenges and a substantial deterioration in financial performance compared to the prior year.
View raw filing on EDGAR →The filing discloses that Capstone received notice from Nasdaq on July 8, 2026, that it has failed to maintain the minimum $1.00 per share bid price requirement and has been granted an additional 180-calendar-day cure period until January 4, 2027, after which Nasdaq will delist the company's common stock if compliance is not regained. This is a direct delisting risk notification under Nasdaq Listing Rule 5550(a)(2), materially affecting the registrant's continued listing status.
View raw filing on EDGAR →Hydrofarm received a determination letter from Nasdaq on July 2, 2026, stating it failed to meet the terms of an extension to regain compliance with the $2.5 million minimum stockholders' equity requirement (Listing Rule 5550(b)(1)). The company also received notice on July 6, 2026, of non-compliance with the minimum bid price requirement (Listing Rule 5550(a)(2)). While the company requested a hearing that stayed delisting action pending the Panel's decision, the disclosure explicitly addresses failure to satisfy continued listing rules and the material risk of delisting, which is the core substance of Item 3.01.
View raw filing on EDGAR →ImmuCell issued a press release on July 9, 2026 announcing preliminary, unaudited Q2 2026 sales results showing an 11.5% increase in product sales compared to Q2 2025 ($7.2M vs. $6.4M), with strong domestic growth of 27.7%. The full press release is attached as Exhibit 99.1, which is the standard format for earnings disclosures under Item 2.02. This is a material earnings announcement that would affect a reasonable investor's assessment of the company's financial performance.
View raw filing on EDGAR →CervoMed announced completion of enrollment in a Phase 2a clinical trial of neflamapimod for nonfluent variant primary progressive aphasia (nfvPPA), with interim biomarker data accepted for presentation at CTAD and full clinical data expected in Q1 2027. This represents a material clinical development milestone for the company's pipeline.
View raw filing on EDGAR →The filing discloses a change in the Company's independent registered public accounting firm: dismissal of Bush & Associates CPA LLC on July 7, 2026, and engagement of M&K CPAS, PLLC on July 2, 2026. This is a classic auditor change under Item 4.01. The materiality is heightened by the fact that Bush & Associates' audit reports included an explanatory paragraph raising substantial doubt about the Company's ability to continue as a going concern, making the auditor transition significant to investors.
View raw filing on EDGAR →The filing discloses both a departure (Cory Nickel's termination as Senior Vice President and General Manager) and an appointment (John Jamieson's appointment to the same role, effective immediately on July 7, 2026). While both events occurred, the principal disclosed action centers on the appointment of Jamieson to a senior operational role with a salary increase from $193,000 to $205,000. The detailed biographical information and Board approval of compensation changes emphasize the appointment as the primary event. This is material as it involves a change in senior management responsible for operations.
View raw filing on EDGAR →Sandra Calvin, the Company's chief accounting officer and principal accounting officer, provided notice on July 6, 2026 of her intention to retire following the filing of the 2027 Form 10-K. While the disclosure also mentions John Torell's expected appointment as her successor, the principal disclosed action is Ms. Calvin's departure. The retirement of a principal accounting officer is material to investors as it affects financial reporting oversight and internal controls.
View raw filing on EDGAR →Edible Garden AG Inc effected a 1-for-45 reverse stock split through a Certificate of Amendment to its Certificate of Incorporation, filed with Delaware on July 8, 2026 and effective July 13, 2026. The reverse stock split materially affects the company's share count and trading mechanics.
View raw filing on EDGAR →This is a straightforward auditor change disclosure under Item 4.01. Fruci & Associates II, PLLC was dismissed effective July 7, 2026, and replaced by Boladale Lawal & Co. as the independent registered public accounting firm. The filing explicitly states no disagreements or reportable events occurred, indicating a routine transition rather than one driven by accounting disputes. Auditor changes are material events affecting investor confidence in financial reporting oversight.
View raw filing on EDGAR →Dreamland Limited entered into a securities purchase agreement on July 7, 2026, to issue 580,000 Class A ordinary shares and 72,000 Class B ordinary shares to Ms. Seto Wai Yue (a director and CEO) for US$2,445,000 in aggregate gross proceeds. The shares are unregistered and issued in reliance on Regulation S as an offshore transaction to a non-U.S. person. This is a classic private placement of equity securities by a foreign private issuer, materially dilutive to existing shareholders and raising capital through an unregistered issuance.
View raw filing on EDGAR →The filing discloses completion of Stereotaxis's acquisition of Robocath for approximately $20 million in cash and Common Stock, as stated in Item 8.01. This is a material acquisition event involving the combination of two robotic surgery companies with complementary technologies and strategic synergies, clearly meeting the definition of M&A activity under Item 1.01/2.01 of the 8-K taxonomy.
View raw filing on EDGAR →The filing discloses that AVAX One has regained compliance with Nasdaq's minimum bid price requirement ($1.00 per share) after previously falling below it on March 13, 2026. While the immediate delisting threat has been resolved, the company is now subject to a mandatory one-year panel monitor under Nasdaq Listing Rule 5815(d)(4)(B), during which any future non-compliance will result in immediate delisting without cure periods. This is a material disclosure of delisting risk and continued listing status, as it materially affects the registrant's ability to maintain its public listing and investor confidence.
View raw filing on EDGAR →The filing discloses an operational update on Eightco's treasury holdings and strategic positioning across three mega-trends (AI, digital identity, creator economy), with specific valuations of holdings in OpenAI ($90M), Beast Industries ($18M), WLD tokens (283M), and ETH (16,278), totaling ~$397M. While the press release emphasizes portfolio composition and market developments affecting those holdings, it does not constitute a formal earnings release, material impairment, M&A activity, or other specifically-defined event type. The disclosure is material to investors assessing the registrant's asset base and strategic direction, but the core event—a treasury/holdings update—fits best within operational_other as a strategic business disclosure that does not match a narrower category.
View raw filing on EDGAR →The exhibit announces the appointment of Brian Hartzband as President of U.S. Operations, a named executive role. The disclosure emphasizes his responsibility for leading U.S. growth strategy, commercial operations, and market expansion—a material operational leadership position. The appointment is presented as a strategic milestone supporting the company's North American expansion and long-term growth execution.
View raw filing on EDGAR →Newton Golf Company exchanged approximately $2.3 million of existing convertible promissory notes for 24,092.61 shares of newly designated Series A Convertible Preferred Stock on July 6, 2026. The Series A Preferred Stock is convertible into Common Stock at $1.00 per share, with forced conversion rights if the stock price reaches $3.00 for 10 consecutive trading days. This represents a dilutive equity issuance that increases the company's share count and potential dilution to existing shareholders, characteristic of a debt-for-equity exchange that raises no new cash but restructures existing obligations into equity form.
View raw filing on EDGAR →Beyond Air implemented a 1-for-20 reverse stock split to "raise the per share bid price of the Company's Common Stock above $1.00 per share and bring the Company back into compliance with Nasdaq Listing Rule 5550(a)(2)." This is a direct response to a delisting risk triggered by the stock price falling below the $1.00 minimum bid price requirement. The filing explicitly states the company was out of compliance and needed to regain it, making this a material delisting-risk disclosure.
View raw filing on EDGAR →The 6-K discloses the resignation of UHY Malaysia PLT as independent auditor effective June 29, 2026, and the appointment of SFAI Malaysia PLT as the new auditor on July 3, 2026. The filing explicitly addresses Item 304 of Regulation S-K, confirming no disagreements or reportable events preceded the change. This is a clear auditor change event material to investors assessing the registrant's financial reporting oversight.
View raw filing on EDGAR →The filing discloses two material operational developments under Item 8.01: (1) a strategic partnership between the AVO brand and the largest college bookstore chain (1,000+ locations), with AVO assuming lululemon's prime retail space; and (2) forward guidance for Q3 2026 projecting $8.5–$11.0 million in revenue (300–500% YoY growth) and positive net income, driven by collegiate expansion (1 to 18 universities) and a landmark government contract. While the guidance contains forward-looking financial projections, the core disclosure centers on operational partnerships and business expansion strategy rather than a formal earnings release or financial results. The partnership and government contract represent material strategic milestones affecting the registrant's business trajectory.
View raw filing on EDGAR →The filing discloses an unregistered private placement of 8,000,000 shares of common stock to Sinco International Investments, Inc. for $25,000 cash under Section 4(a)(2) and Rule 506(b), explicitly covered under Item 3.02 (Unregistered Sales of Equity Securities). This represents a highly dilutive issuance at a minimal valuation ($0.003125 per share), which would materially affect shareholder equity and voting power.
View raw filing on EDGAR →The Company entered into an Equity Transfer Agreement on July 1, 2026, to sell 100% of Mahaotiaodong Information Technology Company (a wholly owned subsidiary holding Code Beating, which provided SMS services in China) to an unrelated third party for US$100. This is a disposition of a material subsidiary, constituting a change of control or divestiture of a business unit. Although the target had ceased operations and carried significant losses (US$1.56 million), the transaction represents a material M&A activity requiring disclosure under Item 1.02 or 2.01 equivalent.
View raw filing on EDGAR →The filing discloses a Nasdaq Hearings Panel determination to delist Bayview Acquisition Corp's securities effective July 7, 2026, due to failure to complete its business combination with Oabay by the June 19, 2026 deadline. This is a direct delisting notice under Item 3.01, representing a terminal loss of exchange listing and a material adverse event for the registrant and its shareholders.
View raw filing on EDGAR →The filing discloses an Equity Purchase Agreement with Hudson Global Ventures, LLC granting the investor the right to purchase up to $15,000,000 of common stock through put notices, plus a warrant to purchase 1,000,000 shares at $0.50 per share. Item 3.02 explicitly confirms unregistered sales of equity securities under Section 4(a)(2) and Regulation D. This is a classic dilutive private placement with a PIPE-like structure, material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →Bone Biologics priced a private offering on July 7, 2026, selling pre-funded warrants and Series F and G warrants to purchase 2,112,677 shares of common stock at a combined purchase price of $1.419 per unit, generating approximately $2.7 million in net proceeds with potential additional gross proceeds of approximately $6 million upon full exercise of the warrants. The securities were issued without registration under Section 4(a)(2) of the Securities Act as a private placement to an accredited investor.
View raw filing on EDGAR →The filing discloses the Board's appointment of Alisa Bowen as Chief Executive Officer of FuboTV, effective July 10, 2026, succeeding co-founder David Gandler. While Gandler's departure is also mentioned, the principal disclosed action centers on the appointment of a new CEO—a veteran media executive with extensive experience at Disney, News Corporation, and other major media organizations. This is a material executive leadership transition at a public company.
View raw filing on EDGAR →The filing discloses Roadzen's entry into a definitive Share Purchase Agreement on July 3, 2026, to acquire Riverside International Holdings Ltd, a European managing general agent specializing in short-term car rental insurance. The transaction is valued at approximately £12 million (approximately $15 million USD) with 50% payable at closing and 50% structured as a three-year earn-out. Item 1.01 explicitly covers "Entry into a Material Definitive Agreement," and the acquisition is material to investors as it represents a significant strategic expansion into the European car rental insurance market with an established, profitable platform generating $18–20 million in annual revenue.
View raw filing on EDGAR →This disclosure announces a 12-for-1 share consolidation approved by the board on June 6, 2026, effective July 14, 2026. The consolidation is a governance and capital structure action undertaken to maintain Nasdaq listing compliance under Rule 5550(a)(2). While not a named governance type (such as an executive appointment or auditor change), it is clearly a material governance/corporate action affecting all shareholders' holdings and the company's continued listing status.
View raw filing on EDGAR →The filing discloses entry into a General Agreement for Omnibus Credit Lines with CTBC Bank on July 3, 2026, establishing a short-term unsecured credit facility of approximately US$1.94 million at 2.5% per annum, maturing September 30, 2026. This is a creation of a direct financial obligation under Item 2.03, fitting the debt_issuance category as a new credit facility arrangement.
View raw filing on EDGAR →The filing discloses under Item 4.01 that on July 9, 2026, the Audit Committee dismissed BCRG as the independent registered public accounting firm and appointed Simon & Edward LLP as the new auditor, effective after S&E acquired BCRG's attest business on June 15, 2026. This is a clear auditor change event. The materiality is heightened by the fact that BCRG's prior audit reports included an explanatory paragraph indicating substantial doubt about the Trust's ability to continue as a going concern, making the auditor transition particularly significant to investors.
View raw filing on EDGAR →The filing discloses a press release issued on July 9, 2026, announcing the Fund's second quarter 2026 private loan portfolio activity, including new commitments of $74.4 million and funded investments of $62.2 million, along with portfolio composition details as of June 30, 2026. This is a periodic financial and operational update typical of earnings releases filed under Item 2.02, disclosing material portfolio metrics and investment activity that would inform investors about the Fund's financial condition and operational performance.
View raw filing on EDGAR →Nurix issued a press release on July 9, 2026, announcing financial results for the fiscal quarter ended May 31, 2026, including revenue of $9.0 million, R&D expenses of $87.7 million, and a net loss of $89.5 million ($0.81 per share). The disclosure is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. While the press release also highlights the Roche collaboration agreement, the primary disclosure is the quarterly financial results.
View raw filing on EDGAR →Cosan discloses execution of an agreement for consensual segregation of land assets in Mato Grosso and new purchase and sale agreements with SLC Agrícola, Bom Futuro, and Alexandre Jacques Bottan. The transaction involves a total value of R$1.85 billion (approximately R$586 million attributable to Cosan's indirect interest) with closing expected by October 30, 2026. This constitutes a material disposition of assets meeting the definition of ma_activity under Item 1.02 or 2.01 of the 8-K taxonomy.
View raw filing on EDGAR →News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transactions totaling approximately $229.3 million in Class A and Class B stock purchases on July 8–9, 2026. While technically a capital allocation rather than a dividend, share repurchases are economically equivalent to distributions and are classified under the dividend_distribution category as a return of capital to shareholders. The filing is material because it represents significant ongoing execution of a shareholder-value-enhancing program and provides transparency on capital deployment.
View raw filing on EDGAR →News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transaction details including 9.1 million Class A shares and 66,163 Class B shares purchased on July 9-10, 2026 for approximately $231 million in aggregate consideration. Share repurchases are a form of capital return to shareholders and constitute a material capital allocation decision affecting shareholder value.
View raw filing on EDGAR →